Amarin Corp Plc (AMRN)

[MedResCollab]

fordyoz, no just quoting the AHA from ca. 2002:

“Patients with CHD should be encouraged to increase their consumption of EPA and DHA to ˜1 g/d, which is the dose used in the GISSI-Prevention Study. Table 3 presents omega-3 fatty acid content of various fish and supplements as well as the amount required each day to provide ˜1 g/d of EPA+DHA. Although this level of EPA and DHA intake potentially can be attained through fish consumption, the requisite amount of fish intake may be difficult to achieve and sustain over the long term. For those individuals who do not eat fish, have limited access to a variety of fish, or cannot afford to purchase fish, a fish oil supplement may be considered. Depending on the preparation, up to three 1-g fish oil capsules per day will be necessary to provide ˜1 g/d of omega-3 fatty acids. The most common fish oil capsules in the United States today provide 180 mg of EPA and 120 mg DHA per capsule. It is important that consumers read the nutrition label to determine EPA and DHA levels in the fish oil capsule.”

https://www.ahajournals.org/doi/full/10.1161/01.CIR.0000038493.65177.94

youre comparing suggesting Diet over Pills in 1999 (where the doses were actually somewhat achievable in diet @ <1g) to suggesting OTC Pills vs. V in 2019. -fordyoz